-
公开(公告)号：EP2768490B1
公开(公告)日：2016-12-07
申请号：EP12841853.0
申请日：2012-10-17
Applicant: St. Teresa Medical Inc.
Inventor： OLSON, Curtis E. , MESSINA, Philip A.
CPC classification number: A61L15/44 , A61K9/7007 , A61K38/363 , A61K38/4833 , A61K47/36 , A61K49/00 , A61L15/28 , A61L2300/418 , A61L2400/04 , A61M5/00 , A61M25/02 , A61M25/10 , C12Y304/21005 , C08L5/02
-
公开(公告)号：EP3373853A1
公开(公告)日：2018-09-19
申请号：EP16864740.2
申请日：2016-10-13
Applicant: St. Teresa Medical, Inc.
Inventor： FLOYD, Timothy , MESSINA, Philip A.
CPC classification number: A61L15/44 , A61K38/363 , A61K38/4833 , A61L15/28 , A61L15/38 , A61L15/64 , A61L2300/418 , A61L2400/04 , A61L2430/32 , A61L2430/34 , A61L2430/36 , C12Y304/21005 , C08L5/02
Abstract: A method of sealing a durotomy from which cerebrospinal fluid is leaking. A durotomy sealant dressing is prepared by applying an active agent to a dextran base. The durotomy sealant dressing is applied to a durotomy. At least a portion of the durotomy sealant dressing dissolves. The durotomy is sealed with the dissolved durotomy sealant dressing to substantially prevent cerebrospinal fluid from flowing through the durotomy.
-
Patent Agency Ranking
公开(公告)号：EP3525811A1
公开(公告)日：2019-08-21
申请号：EP17859998.1
申请日：2017-10-11
Applicant: St. Teresa Medical, Inc.
Inventor： FLOYD, Timothy , MESSINA, Philip A.
-
公开(公告)号：EP2768490A1
公开(公告)日：2014-08-27
申请号：EP12841853.0
申请日：2012-10-17
Applicant: St. Teresa Medical Inc.
Inventor： OLSON, Curtis E. , MESSINA, Philip A.
CPC classification number: A61L15/44 , A61K9/7007 , A61K38/363 , A61K38/4833 , A61K47/36 , A61K49/00 , A61L15/28 , A61L2300/418 , A61L2400/04 , A61M5/00 , A61M25/02 , A61M25/10 , C12Y304/21005 , C08L5/02
Abstract: A hemostatic product that includes a dextran support, at least one hemostatic agent and at least one hemostatic agent stabilizer. The at least one hemostatic agent is selected from the group consisting of thrombin and fibrinogen. The at least one hemostatic agent is associated with the dextran support. The at least one hemostatic agent stabilizer is associated with the at least one hemostatic agent.
Abstract translation: 一种具有多个止血层的止血产品。 每个止血层包括葡聚糖载体和至少一种选自凝血酶和纤维蛋白原的止血剂。 止血层以堆叠构造排列。
-
公开(公告)号：EP2768540B1
公开(公告)日：2018-12-05
申请号：EP12841666.6
申请日：2012-10-17
Applicant: St. Teresa Medical, Inc.
Inventor： OLSON, Curtis E. , MESSINA, Philip A.
CPC classification number: A61L15/44 , A61K9/7007 , A61K38/363 , A61K38/4833 , A61K47/36 , A61K49/00 , A61L15/28 , A61L2300/418 , A61L2400/04 , A61M5/00 , A61M25/02 , A61M25/10 , C12Y304/21005 , C08L5/02
Abstract: A method of forming hemostatic sheets. Dextran and water are mixed to form a dextran-water mixture. The dextran-water mixture is formed into a first support layer. Fibrinogen and thrombin are mixed to form a fibrinogen and thrombin mixture. The fibrinogen and thrombin mixture is dispersed on the first support layer to form a hemostatic sheet.
-
公开(公告)号：EP2768541A1
公开(公告)日：2014-08-27
申请号：EP12842651.7
申请日：2012-10-17
Applicant: St. Teresa Medical Inc. , Olson, Curtis E. , Messina, Philip A. , Jackson, Brian Jeffrey
Inventor： OLSON, Curtis E. , MESSINA, Philip A. , JACKSON, Brian Jeffrey
CPC classification number: A61L15/44 , A61F13/00063 , A61K38/363 , A61K38/48 , A61L15/24 , A61L15/26 , A61L15/32 , A61L2400/04 , C08L5/02 , C08L67/04
Abstract: A method of forming hemostatic sheets. Dextran and water are mixed to form a dextran-water mixture. The dextran-water mixture is formed into a first support layer. Fibrinogen and thrombin are mixed to form a fibrinogen and thrombin mixture. The fibrinogen and thrombin mixture is dispersed on the first support layer to form a hemostatic sheet.
-
7.发明公开
公开(公告)号：EP2768540A1
公开(公告)日：2014-08-27
申请号：EP12841666.6
申请日：2012-10-17
Applicant: St. Teresa Medical Inc.
Inventor： OLSON, Curtis E. , MESSINA, Philip A.
CPC classification number: A61L15/44 , A61K9/7007 , A61K38/363 , A61K38/4833 , A61K47/36 , A61K49/00 , A61L15/28 , A61L2300/418 , A61L2400/04 , A61M5/00 , A61M25/02 , A61M25/10 , C12Y304/21005 , C08L5/02
Abstract: A hemostatic product having a plurality of hemostatic layers. Each of the hemostatic layers includes a dextran support and at least one hemostatic agent, which is selected from the group consisting of thrombin and fibrinogen. The hemostatic layers are arranged in a stacked configuration. The hemostatic layers may include other biactive agents.
Abstract translation: 一种具有多个止血层的止血产品。 每个止血层包括葡聚糖载体和至少一种选自凝血酶和纤维蛋白原的止血剂。 止血层以堆叠构造排列。
-
-
-
-
-
-
Search Results
7
records
(took 0.017 seconds)
